ATHA
Athira Pharma, Inc. - Common Stock (ATHA)
$14
About Athira Pharma, Inc. - Common Stock (ATHA)
Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Details
Daily high
$4.17
Daily low
$3.90
Price at open
$3.90
52 Week High
$6.08
52 Week Low
$2.20
Market cap
15.3M
Dividend yield
0.00%
Volume
25,887
Avg. volume
18,823
P/E ratio
-.40
Athira Pharma, Inc. - Common Stock News
Details
Daily high
$4.17
Daily low
$3.90
Price at open
$3.90
52 Week High
$6.08
52 Week Low
$2.20
Market cap
15.3M
Dividend yield
0.00%
Volume
25,887
Avg. volume
18,823
P/E ratio
-.40